Ledan Wang
Impact in
-
- Cancer-related molecular mechanisms research
Papers in
-
- Retinal Diseases and Treatments 2
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Fang Wang (1 shared paper)Yi Liu (1 shared paper)Changzhong Li (1 shared paper)Wenjuan Huang (3 shared papers)Xiangyang Xue (3 shared papers)Sisi Ye (1 shared paper)Xiangwei Sun (1 shared paper)Ping Duan (1 shared paper)
- Journals
- ACS Nano (3 papers)Oncotarget (2 papers)Journal of Ocular Pharmacology and Therapeutics (2 papers)Advanced Science (2 papers)International Journal of Nanomedicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ledan Wang
23 papers receiving 473 citations
Peers
Comparison fields: 5 of 64
- Drug Discovery 2
- Cancer Research 84
- Health, Toxicology and Mutagenesis 82
- Biomaterials 47
- Ophthalmology 22
Countries citing papers authored by Ledan Wang
This map shows the geographic impact of Ledan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ledan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ledan Wang more than expected).
Fields of papers citing papers by Ledan Wang
This network shows the impact of papers produced by Ledan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ledan Wang. The network helps show where Ledan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ledan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 88 | |
| 2 | 2017 | 85 | |
| 3 | 2020 | 38 | |
| 4 | 2016 | 31 | |
| 5 | 2018 | 28 | |
| 6 | 2023 | 27 | |
| 7 | 2014 | 25 | |
| 8 | 2017 | 25 | |
| 9 | 2011 | 23 | |
| 10 | 2023 | 23 | |
| 11 | 2019 | 21 | |
| 12 | 2024 | 17 | |
| 13 | 2013 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2025 | 9 | |
| 16 | 2017 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2020 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 4 |
About Ledan Wang
Ledan Wang is a scholar working on Ophthalmology, Biomaterials, Biochemistry, Reproductive Medicine and Hematology, having authored 24 papers that have together received 490 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers), Blood transfusion and management (2 papers), Blood groups and transfusion (2 papers), Ocular Surface and Contact Lens (2 papers), Synthesis and biological activity (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Drug Discovery (2 citations), Cancer Research (84 citations), Health, Toxicology and Mutagenesis (82 citations), Biomaterials (47 citations) and Ophthalmology (22 citations). Ledan Wang has collaborated with scholars based in China and United States. Frequent co-authors include Fang Wang, Yi Liu, Changzhong Li, Wenjuan Huang, Xiangyang Xue, Sisi Ye, Xiangwei Sun, Ping Duan, Yingying Hu and Jianfeng Xu. Their work appears in journals such as ACS Nano, Oncotarget, Journal of Ocular Pharmacology and Therapeutics, Advanced Science and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.